CN112791147A - Traditional Chinese medicine for treating nodules of breast and preparation method thereof - Google Patents
Traditional Chinese medicine for treating nodules of breast and preparation method thereof Download PDFInfo
- Publication number
- CN112791147A CN112791147A CN202110147212.2A CN202110147212A CN112791147A CN 112791147 A CN112791147 A CN 112791147A CN 202110147212 A CN202110147212 A CN 202110147212A CN 112791147 A CN112791147 A CN 112791147A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- ginseng
- breast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 127
- 238000002360 preparation method Methods 0.000 title claims abstract description 42
- 210000000481 breast Anatomy 0.000 title claims abstract description 25
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 28
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 25
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 25
- 235000008434 ginseng Nutrition 0.000 claims abstract description 25
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 24
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 24
- 244000197580 Poria cocos Species 0.000 claims abstract description 24
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 24
- 241000935235 Fritillaria meleagris Species 0.000 claims abstract description 23
- 240000004980 Rheum officinale Species 0.000 claims abstract description 23
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 22
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 22
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 18
- 229940079593 drug Drugs 0.000 claims abstract description 18
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 17
- 241000218989 Trichosanthes Species 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 7
- 244000170916 Paeonia officinalis Species 0.000 claims abstract 2
- 239000008187 granular material Substances 0.000 claims description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 39
- 239000000843 powder Substances 0.000 claims description 37
- 239000000463 material Substances 0.000 claims description 36
- 238000001914 filtration Methods 0.000 claims description 31
- 239000000706 filtrate Substances 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 25
- 238000002156 mixing Methods 0.000 claims description 24
- 238000001035 drying Methods 0.000 claims description 21
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 18
- 239000008517 radix Trichosanthis Substances 0.000 claims description 14
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 9
- 238000007873 sieving Methods 0.000 claims description 8
- 241000243684 Lumbricus Species 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 2
- 241000125175 Angelica Species 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 35
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 23
- 208000002193 Pain Diseases 0.000 abstract description 22
- 206010006272 Breast mass Diseases 0.000 abstract description 11
- 208000024891 symptom Diseases 0.000 abstract description 10
- 210000000038 chest Anatomy 0.000 abstract description 6
- 208000019914 Mental Fatigue Diseases 0.000 abstract description 3
- 230000002175 menstrual effect Effects 0.000 abstract description 3
- 208000006083 Hypokinesia Diseases 0.000 abstract description 2
- 208000031975 Yang Deficiency Diseases 0.000 abstract description 2
- 208000035475 disorder Diseases 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 description 47
- 239000008280 blood Substances 0.000 description 47
- 230000000694 effects Effects 0.000 description 34
- 239000000284 extract Substances 0.000 description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- 229920001661 Chitosan Polymers 0.000 description 23
- 240000004371 Panax ginseng Species 0.000 description 19
- 239000003085 diluting agent Substances 0.000 description 19
- 201000010099 disease Diseases 0.000 description 19
- 206010020718 hyperplasia Diseases 0.000 description 17
- 210000000952 spleen Anatomy 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 206010062717 Increased upper airway secretion Diseases 0.000 description 16
- 210000005075 mammary gland Anatomy 0.000 description 16
- 208000026435 phlegm Diseases 0.000 description 16
- 238000000746 purification Methods 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 11
- 150000004676 glycans Chemical class 0.000 description 11
- 229920001282 polysaccharide Polymers 0.000 description 11
- 239000005017 polysaccharide Substances 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 9
- 208000004998 Abdominal Pain Diseases 0.000 description 8
- 244000061520 Angelica archangelica Species 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 6
- 229930195725 Mannitol Natural products 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 229930003935 flavonoid Natural products 0.000 description 6
- 150000002215 flavonoids Chemical class 0.000 description 6
- 235000017173 flavonoids Nutrition 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 229940088597 hormone Drugs 0.000 description 6
- 239000005556 hormone Substances 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000000594 mannitol Substances 0.000 description 6
- 235000010355 mannitol Nutrition 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010006298 Breast pain Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 208000006662 Mastodynia Diseases 0.000 description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 5
- 241001106477 Paeoniaceae Species 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 238000005189 flocculation Methods 0.000 description 5
- 230000016615 flocculation Effects 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 235000008216 herbs Nutrition 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000008108 microcrystalline cellulose Substances 0.000 description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229920001864 tannin Polymers 0.000 description 5
- 239000001648 tannin Substances 0.000 description 5
- 235000018553 tannin Nutrition 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 241001301736 Lumbriculidae Species 0.000 description 4
- 208000019255 Menstrual disease Diseases 0.000 description 4
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 4
- 244000236658 Paeonia lactiflora Species 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 4
- 229940011871 estrogen Drugs 0.000 description 4
- 239000000262 estrogen Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 229930003944 flavone Natural products 0.000 description 4
- 150000002212 flavone derivatives Chemical class 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 230000003821 menstrual periods Effects 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 244000075634 Cyperus rotundus Species 0.000 description 3
- 241000931143 Gleditsia sinensis Species 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 241000180649 Panax notoginseng Species 0.000 description 3
- 235000003143 Panax notoginseng Nutrition 0.000 description 3
- 241000219061 Rheum Species 0.000 description 3
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 206010000269 abscess Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 241000345998 Calamus manan Species 0.000 description 2
- 235000008671 Calycanthus floridus Nutrition 0.000 description 2
- 244000025311 Calycanthus occidentalis Species 0.000 description 2
- 235000008670 Calycanthus occidentalis Nutrition 0.000 description 2
- 241000282461 Canis lupus Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010010947 Coordination abnormal Diseases 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 235000004520 Lindera benzoin Nutrition 0.000 description 2
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 229920000715 Mucilage Polymers 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 206010034568 Peripheral coldness Diseases 0.000 description 2
- 241000219050 Polygonaceae Species 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000304195 Salvia miltiorrhiza Species 0.000 description 2
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 230000003311 flocculating effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229960001031 glucose Drugs 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 208000016290 incoordination Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000006651 lactation Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 235000012950 rattan cane Nutrition 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000007779 soft material Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 241001614060 Amynthas aspergillus Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 241000334161 Cercis chinensis Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000723347 Cinnamomum Species 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 241000234653 Cyperus Species 0.000 description 1
- 235000018109 Cyperus longus Nutrition 0.000 description 1
- 244000150195 Cyperus longus Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 241001289529 Fallopia multiflora Species 0.000 description 1
- 241000605372 Fritillaria Species 0.000 description 1
- 241001547125 Fritillaria thunbergii Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 235000002598 Inula helenium Nutrition 0.000 description 1
- 244000116484 Inula helenium Species 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 240000007890 Leonurus cardiaca Species 0.000 description 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 description 1
- 241000112528 Ligusticum striatum Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 241000099813 Metaphire guillelmi Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 1
- 102000003946 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 241000691155 Pteris multifida Species 0.000 description 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 description 1
- 244000081426 Ranunculus ficaria Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 235000008090 Rheum palmatum Nutrition 0.000 description 1
- 240000001745 Rheum palmatum Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 235000005010 Scirpus paludosus Nutrition 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 241000800405 Spatholobus suberectus Species 0.000 description 1
- 235000004338 Syringa vulgaris Nutrition 0.000 description 1
- 244000297179 Syringa vulgaris Species 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 description 1
- 240000006023 Trichosanthes kirilowii Species 0.000 description 1
- 241000975594 Trichosanthes rosthornii Species 0.000 description 1
- 244000178320 Vaccaria pyramidata Species 0.000 description 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 208000021017 Weight Gain Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 description 1
- 229960002802 bromocriptine Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 241001233061 earthworms Species 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000011841 epidemiological investigation Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 235000008113 selfheal Nutrition 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating nodules of breast and a preparation method thereof, wherein the traditional Chinese medicine is prepared from the following raw material medicines in parts by weight: 90-110 parts of radix linderae, 90-110 parts of caulis spatholobi, 70-90 parts of ginseng, 70-90 parts of cassia twig, 50-70 parts of white paeony root, 50-70 parts of rhizoma cyperi, 50-70 parts of angelica sinensis, 50-70 parts of rheum officinale, 50-70 parts of earthworm, 50-70 parts of poria cocos, 50-70 parts of thunberg fritillary bulb, 50-70 parts of pseudo-ginseng, 40-60 parts of spina gleditsiae and 40-60 parts of trichosanthes root. The traditional Chinese medicine can be clinically used for treating symptoms of lump and pain in breast, small menstrual flow, intolerance of cold, chest and hypochondrium distending pain, mental fatigue and hypodynamia and the like, and is particularly suitable for breast nodules with symptoms of Chong and conception vessel disorder, liver depression and qi stagnation accompanied with yang deficiency.
Description
Technical Field
The invention relates to a traditional Chinese medicine for treating nodules of breast and a preparation method thereof, belonging to the field of traditional Chinese medicines.
Background
Mammary nodules (mammary hyperplasia in Western medicine for short) are a common proliferative mammary disease, which is frequently seen in middle-aged and young women, and the incidence rate of the hyperplasia accounts for the front row of all mammary diseases. The essence of the disease is the degenerative changes in the structure of ducts and milk lobules in the mammary tissue and the progressive growth of connective tissue. According to the results of epidemiological investigation, as the social status of women rises and the responsibility of participating in social affairs becomes heavier, the work and life pressure of the women increases, and the incidence rate of the women reaches 70-80% in some areas. And the incidence rate in most urban areas is higher than that in rural areas, the incidence of the disease presents the characteristic of youthful appearance and tends to rise year by year. The patients are most common to women of 30-50 years old and mainly have symptoms of breast pain, breast lumps and the like in clinic. Modern studies have shown that when estrogen or progestin imbalance, which causes a decrease in luteinizing hormone, is highly correlated with the secretion of hormones in women, the estrogen increases and the mammary tissue is stimulated by the estrogen to form hyperplasia in the ducts and lobules of the mammary tissue, resulting in the disease.
The traditional Chinese medicine considers that: hyperplasia of mammary glands is mainly caused by phlegm turbidity generated in the breast due to emotional disorder, stagnation of liver qi, incoordination between liver and stomach, etc.; or disharmony of thoroughfare and conception vessels, which can cause phlegm accumulation for a long time. The hyperplasia of mammary glands belongs to the category of mammary nodules in the traditional Chinese medicine. It is highly related to liver-qi stagnation and disharmony of thoroughfare and conception vessels in women. According to the traditional Chinese medicine, the liver pulse is distributed in the chest and hypochondrium, the nipple is blue and belongs to the liver, and if the liver is not smooth and the veins in the chest and hypochondrium are obstructed, the qi activity of the breast is not smooth, so that the breast is distended and painful. The breast of women is the organ for qi and blood and milk perfusion, and is easy to generate qi stagnation, blood stasis and phlegm coagulation. The disease is also caused by dysfunction of spleen in transportation, endogenous phlegm-dampness, intermingled phlegm and qi, and obstruction of channels and collaterals is nodules of breast; over-exertion, insufficiency of the liver and kidney, or insufficiency of the spleen and kidney yang, accumulation of phlegm-dampness, and obstruction of the meridians can lead to breast pain.
At present, western medicine therapy is available for treating the breast nodule diseases, including clinical surgery and drug therapy, the surgical therapy is mainly to perform fixed-point excision and the like through breast lumps, while western medicine treatment traditional hormone preparations mainly use male hormone to resist estrogen, but the administration of male hormone drugs may have side effects of liver damage, dizziness, nausea and the like. For mastoproliferation caused by endocrine disorder, which is the imbalance of ovarian endocrine hormone, and is also affected by endocrine hormones such as hypothalamus and pituitary, patients can use bromocriptine to inhibit prolactin secretion, but the side effects of these drugs can be amenorrhea, menostaxis, weight gain, etc. Therefore, the western medicines for the diseases have large toxic and side effects on patients, but the traditional Chinese medicine has unique advantages in treating the diseases and has the advantages of definite curative effect and small toxic and side effects.
We systematically tease out the patents and documents that are closely related to the prior art of the present invention by referring to patent and document databases and summarize the following: patent document with publication number CN101524452A reports: a Chinese medicinal composition for treating hyperplasia of mammary glands comprises effective components and/or pharmaceutically acceptable carriers, wherein the effective components are prepared by extracting radix bupleuri, rhizoma cyperi, ligusticum wallichii, salvia miltiorrhiza, red paeony root, white paeony root, caulis spatholobi, angelica sinensis, cowherb seed, figwort root, selfheal, poria cocos, liquorice and the like. The medicine has effects of dispersing stagnated liver qi, resolving stagnation, removing blood stasis, eliminating phlegm and resolving hard mass, and is mainly used for treating hyperplasia of mammary glands, benign tumor of mammary glands, acute mastitis, etc. Patent document No. CN102058845A discloses: a pharmaceutical composition for treating macular degeneration, 10-40 parts of radix astragali, 10-40 parts of angelica, 10-40 parts of tuckahoe, 5-20 parts of thunberg fritillary bulb, 3-18 parts of pseudo-ginseng, 1-10 parts of rhubarb charcoal, 10-40 parts of raw pollen typhae and 10-40 parts of radix curcumae. The application of a traditional Chinese medicine preparation in preparing an external patch for treating irregular menstruation is also described in the patent application with the publication number of CN104906307A, and the traditional Chinese medicine preparation is characterized by being prepared from the following raw material medicines in parts by weight: 5-10 parts of angelica sinensis, 10-15 parts of fructus evodiae, 15-20 parts of salvia miltiorrhiza, 5-10 parts of pteris multifida, 15-20 parts of donkey-hide gelatin, 10-15 parts of perilla, 10-15 parts of caulis spatholobi, 10-15 parts of rhizoma cyperi, 5-10 parts of elecampane, 3-8 parts of spina date seeds, 2-8 parts of common yam rhizome, 5-10 parts of semen cuscutae, 15-20 parts of cassia twig, 5-10 parts of motherwort, 5-10 parts of dandelion, 10-15 parts of combined spicebush root, 5-10 parts of Chinese redbud bark, 5-10 parts of grape root, 5-10 parts of cinnamon, 5-10 parts of lilac and 5-10 parts of rhizoma alismatis. The medicine has remarkable curative effect on menoxenia, and is convenient for application. In addition, no obvious adverse reaction is found in the application process, but the medicines have the defects of overlarge formula, indefinite active substance components and the like, and the traditional Chinese medicine has the obvious advantages of accumulating rich clinical experience knowledge in the aspect of treating hyperplasia of mammary glands. Therefore, the development of a Chinese medicinal preparation with reliable clinical curative effect is very important.
Disclosure of Invention
The technical problem to be solved by the invention is to provide a traditional Chinese medicine for treating nodules of breast and a preparation method thereof. Another object of the invention is: the preparation method has the advantages that the preparation process is stable and reliable, the effective substance components of the traditional Chinese medicine can be effectively enriched, and the stability of the traditional Chinese medicine particles can be improved. The preparation method has stable and reliable technological parameters, and has obvious advantages in industrialization prospect.
The mammary gland hyperplasia belongs to the category called as the breast nodule disease in the traditional Chinese medicine, the aetiology of the mammary gland hyperplasia is depressed due to the fact that women are calm, irritable and dysphoria, the female takes the liver as the congenital foundation, the liver fails to reach the original condition, the qi movement is not comfortable, the qi stagnation occurs, the symptom of liver qi stagnation occurs, the qi and blood are dependent, the qi and blood circulation is not smooth, the breast meridian is blocked, the obstruction causes pain, the breast pain is caused, and the qi stagnation and the blood stasis are accumulated as the nucleus. The spleen failing to transport and transform and phlegm-dampness failing to nourish the Chong and ren channels. Failure to warm spleen yang will not transport and transform food fluids, gather dampness and form phlegm, long-term stagnation of liver qi will transform into heat and internal fire, scorching fluid into phlegm, and then qi and blood stasis will form nodules of breast.
After years of clinical experience and repeated dialectical summary research, the inventor finally finds out a prescription with remarkable clinical curative effect for treating the nodules of breast. The symptoms of distending pain in the hypochondrium and breast agglomeration are caused by stagnation of liver qi in women with hyperplasia of mammary glands. Therefore, the combination of radix Linderae and caulis Spatholobi is the principal drug in the recipe. Wu Yao, pungent and warm in flavor, is good at warming kidney and descending energizer and has the actions of guiding qi downward and alleviating pain. Also, the stagnation of liver qi may lead to the obstruction of qi movement, so that food, body fluids and menstrual blood cannot fill uterus and overflow breast, which may cause obstruction of mammary vessels, coagulation and pain due to qi and blood obstruction. The combination of caulis Spatholobi for its action of tonifying blood is bitter but not dry, warm but not drastic, good at dispelling blood stasis. However, in clinical practice, it is found that most of the patients with mammary nodules are accompanied by the symptoms of abdominal pain, preference for warmth, cold hands and feet, and pale and white tongue coating. The etiology of the disease is determined, and women cold pathogen can affect the circulation of blood and qi by invading the Chong channel and the ren channel, so that the abdominal pain is caused by the formation of blood stasis.
The ginseng is used as the minister of the recipe, is sweet and warm, can improve cold womb of women, can greatly tonify spleen and lung vigor, promote the production of body fluid and calm the nerves. In the book Ben Cao Hui Yan, it is said to tonify qi and generate blood, and the recipe is used mainly to tonify qi and generate blood to help women's blood vessels through the whole body. And the cassia twig is matched to achieve warm nature, promote and remove yang qi, warm and remove cold. The two medicines are matched as ministerial medicines, and the qi is vigorous to promote blood circulation, so that the Chong and ren blood of women can be filled, and the whole blood vessels of women can be benefited.
The auxiliary materials in the prescription are white paeony root, bitter, sour and cold in taste, enter liver and spleen meridians, and have the effects of astringing yin, nourishing blood, softening liver and relieving pain. Treating both ying and wei, dispersing and contracting, warming yang and releasing exterior, opening striae, and leading yang qi to be expressed from inside to the whole body. The white peony root can also prevent the yin and body fluids from being damaged by the excessive evacuation of the pungent and warm monarch and ministerial drugs in the formula. The auxiliary material is added with nutgrass galingale rhizome which is good at dispersing and can enter blood system, is called as 'blood qi-regulating medicine' and can pass through twelve meridians, sooth liver and regulate qi, regulate menstruation and relieve pain. Because qi and blood depend on each other, qi can generate blood and promote blood circulation, so the formula combined with Dang Gui can tonify blood and promote blood circulation. For women with liver depression and blood stagnation for a long time, it must generate heat and internal fire. The rhubarb is matched with the prescription, so the medicine is bitter and cold, can clear away heat and blood stasis, and wash away damp-heat and blood stasis toxin in the intestines. Assisting with the sexual movement of earthworm, it can move through meridians and collaterals, break blood and remove stasis. Poria may be added to strengthen spleen and dry dampness. With Zhejiang fritillaria bulb, it can resolve phlegm and dissipate nodulation to promote lactation. So as to make the spleen healthy and well-moving and eliminate turbid phlegm internally. The addition of notoginseng, which is sweet and warm in nature, can better dispel blood stasis without damaging the body resistance, is a delicate product for regulating blood and can enhance the functions of promoting blood circulation and removing obstruction in channels in the formula, and the above medicines are matched as adjuvant medicines. Finally, with the addition of Chinese honeylocust spine, it can resolve swelling and expel pus, and can direct the herbs upward to treat mammary abscess in upper energizer. The last prescription is matched with trichosanthes root, and has the functions of clearing heat, promoting fluid, detoxifying and eliminating carbuncle. The medicines are matched to play the efficacies of promoting qi circulation, warming yang, nourishing blood, dredging collaterals, reducing phlegm and resolving masses, can enable women to be full of blood and smooth qi and blood, and can sooth liver, relieve depression, soften hardness and dissipate blood stasis to eliminate nodules of breast, relieve pain and achieve the aim of curing.
The technical scheme provided by the invention is as follows:
the dosage of the traditional Chinese medicine is obtained by a large amount of grope and summary, and the dosage of each component has better curative effect within the following weight part range.
The invention aims to provide a traditional Chinese medicine for treating nodules of breast, which is prepared from the following raw material medicines in parts by weight: 90-110 parts of radix linderae, 90-110 parts of caulis spatholobi, 70-90 parts of ginseng, 70-90 parts of cassia twig, 50-70 parts of white paeony root, 50-70 parts of rhizoma cyperi, 50-70 parts of angelica sinensis, 50-70 parts of rheum officinale, 50-70 parts of earthworm, 50-70 parts of poria cocos, 50-70 parts of thunberg fritillary bulb, 50-70 parts of pseudo-ginseng, 40-60 parts of spina gleditsiae and 40-60 parts of trichosanthes root.
As the optimization of the traditional Chinese medicine prescription, the traditional Chinese medicine is prepared from the following raw materials in parts by weight: 95-105 parts of radix linderae, 95-105 parts of caulis spatholobi, 75-85 parts of ginseng, 75-85 parts of cassia twig, 55-65 parts of radix paeoniae alba, 55-65 parts of rhizoma cyperi, 55-65 parts of angelica sinensis, 55-65 parts of rheum officinale, 55-65 parts of lumbricus, 55-65 parts of poria cocos, 55-65 parts of thunberg fritillary bulb, 55-65 parts of pseudo-ginseng, 45-55 parts of spina gleditsiae and 45-55 parts of trichosanthes root.
The traditional Chinese medicine prescription is further preferred, and the traditional Chinese medicine is prepared from the following raw materials in parts by weight: 110 parts of radix linderae, 90 parts of caulis spatholobi, 90 parts of ginseng, 90 parts of cassia twig, 70 parts of radix paeoniae alba, 50 parts of rhizoma cyperi, 70 parts of angelica, 50 parts of rheum officinale, 70 parts of lumbricus, 50 parts of poria cocos, 70 parts of thunberg fritillary bulb, 70 parts of pseudo-ginseng, 60 parts of spina gleditsiae and 40 parts of trichosanthes root.
The preparation method of the traditional Chinese medicine for nodules of breast comprises the following steps:
taking radix linderae, caulis spatholobi, ginseng, cassia twig, radix paeoniae alba, rhizoma cyperi, angelica sinensis, rheum officinale, earthworm, poria cocos, thunberg fritillary bulb, pseudo-ginseng, spina gleditsiae and radix trichosanthis, adding water 7-10 times of the weight of the medicinal materials for the first time, decocting for 0.5-2 hours, filtering, adding water 6-9 times of the weight of the medicinal materials for the second time, decocting for 0.5-1 hour, filtering, combining water filtrates of the two times, concentrating the filtrate under reduced pressure into a clear paste with the relative density of 1.02-1.06, concentrating and drying under reduced pressure to obtain dry paste powder, crushing and sieving to obtain mixed dry paste fine powder;
the method comprises the steps of mixing fine dry paste powder, uniformly mixing, and adding common auxiliary materials in pharmacy.
As the optimization of the preparation method of the traditional Chinese medicine for nodules of breast, the preparation method comprises the following steps:
the preparation method comprises the steps of taking radix linderae, caulis spatholobi, ginseng, cassia twig, radix paeoniae alba, rhizoma cyperi, angelica sinensis, rheum officinale, earthworm, poria cocos, thunberg fritillary bulb, pseudo-ginseng, spina gleditsiae and radix trichosanthis, adding water 9 times the weight of the medicinal materials for the first time, decocting for 1 hour, filtering, adding water 8 times the weight of the medicinal materials for the second time, decocting for 0.6 hour, filtering, combining water filtrate obtained in the two times, concentrating the filtrate under reduced pressure into a clear paste with the relative density of 1.02-1.06, concentrating and drying under reduced pressure to obtain dry paste powder, crushing and sieving to obtain mixed dry paste fine powder;
the method comprises the steps of mixing fine dry paste powder, uniformly mixing, and adding common auxiliary materials in pharmacy.
Preferably, the clear paste in the preparation method further comprises purifying by using a chitosan solution, wherein the concentration of the chitosan solution is 3%, the amount of the added chitosan solution is 10% of the volume of the traditional Chinese medicine purification liquid, the adding temperature is controlled at 50 ℃, and the stirring time is 10 minutes.
The dosage form of the traditional Chinese medicine is preferably granules.
The traditional Chinese medicine comprises a traditional Chinese medicine formula which is similar to the traditional Chinese medicine formula and contains the medicinal materials of radix linderae, caulis spatholobi, ginseng, cassia twig, radix paeoniae alba, rhizoma cyperi, angelica sinensis, rheum officinale, lumbricus, poria cocos, thunberg fritillary bulb, pseudo-ginseng, spina gleditsiae, radix trichosanthis and the like.
The invention improves the preparation process technology
However, the decoction of the traditional Chinese medicine is prepared by decocting and extracting the traditional Chinese medicine in mixed water, so that the traditional Chinese medicine extract contains a large amount of starch, mucilage or tannin and other impurity components, and has the defects of inconvenient carrying, difficult storage, poor taste and the like. If the granules prepared by conventional concentration and extraction are adopted, the granules are found to be easy to absorb moisture in a stability investigation stage, so that a large number of preliminary tests are carried out in a test research stage, and in a preparation process research process, a chitosan flocculation method is accidentally found in an extracting solution purification process, so that the retention of active ingredients such as total flavonoids, total polysaccharides and the like in the traditional Chinese medicine can be increased, and better removal effects on impurities such as tannin, mucoid and the like can be achieved, so that the stability of the granules can be increased.
In order to further illustrate the superiority of the technical scheme of the technical process of the invention, the specific experimental contents are as follows.
Test 1 group preparation of the Chinese medicinal extract of the present invention
The optimal prescription composition and proportion of the invention are as follows:
the traditional Chinese medicine composition has the following best experience formula: 100g of radix linderae, 100g of caulis spatholobi, 80g of ginseng, 80g of cassia twig, 60g of radix paeoniae alba, 60g of rhizoma cyperi, 60g of angelica, 60g of rheum officinale, 60g of earthworm, 60g of poria cocos, 60g of thunberg fritillary bulb, 60g of pseudo-ginseng, 50g of spina gleditsiae and 50g of radix trichosanthis;
the preparation method comprises the following steps: the method comprises the steps of taking radix linderae, caulis spatholobi, ginseng, cassia twig, radix paeoniae alba, rhizoma cyperi, angelica sinensis, rheum officinale, earthworm, poria cocos, thunberg fritillary bulb, pseudo-ginseng, spina gleditsiae and radix trichosanthis, adding water 9 times the weight of the medicinal materials for the first time, decocting for 1h, filtering, adding water 8 times the weight of the medicinal materials for the second time, decocting for 0.6h, filtering, combining water filtrates of the two times, concentrating, filtering to obtain an analysis sample, and measuring the content of total flavonoids in the traditional Chinese medicine extracting solution for later use.
And (3) determining the extract yield:
precisely measuring 50ml of the above compound Chinese medicinal decoction, placing in a constant weight evaporating dish, drying at 105 deg.C to constant weight, and weighing. The method for calculating the extract yield comprises the following steps: the extract yield (%) -, the amount of extract solid in the extract/the amount of fed material x 100%.
And (3) total flavone content determination:
the invention adopts an ultraviolet spectrophotometry, wherein rutin is taken as a reference substance, sodium nitrite, aluminum nitrate, sodium hydroxide and the like are taken as color developing agents, and the absorbance (A) is measured at the wavelength of 508nm under an ultraviolet lamp. The linear range of the detection concentration of the rutin solution is 12-72 mug/mL (r is 0.9993), the RSD of the precision, stability and repeatability tests of the test method is less than 3%, the sample recovery rate is 99.69-102.76%, and the detection result shows that the method is accurate and reliable, has good linearity and stability, and can be used for determining the content of total flavonoids in the decoction extract of Chinese medicinal herbs.
Total polysaccharide assay
The content of total polysaccharide in the traditional Chinese medicine extracting solution is determined by adopting a phenol-sulfuric acid method, taking a glucose standard substance as a reference substance and adopting an ultraviolet-visible spectrophotometry method. Wherein the maximum absorption wavelength of total polysaccharide ultraviolet measurement is 621nm, the mass concentration range of anhydrous glucose is 0.021-0.126 mg/ml, and the absorbance and the concentration form a good linear relationship. The precision, stability and repeatability of the test method are all less than 3.6 percent, the sample recovery rate is 98.34-103.52 percent, and the result shows that the method is simple, convenient, accurate, reliable in repeatability and stability and can be used as a method for measuring the content of total polysaccharides in a decoction extract of Chinese herbal medicines.
TABLE 1 measurement results of the contents of effective substances in the Chinese medicinal extract of the present invention
From the experimental results in Table 1, the extract yield of the Chinese medicinal extract of the present invention is about 21.7%, the total flavone content of the extract is about 5.56mg/mL, and the total polysaccharide content is 9.53 mg/mL.
Experiment 2 group of the present invention on the purification process of the Chinese medicinal extract
The Chinese medicine extract prepared by the preparation method of the test 1 group is purified by the following 3 different processes. Wherein, in test 1, the Chinese medicine extract clear paste is taken, 3 percent of chitosan solution is added, the amount of the added chitosan solution is 5 percent of that of the Chinese medicine extract, the temperature is 50 ℃, the heating and stirring time is 10min, the Chinese medicine extract liquid is naturally cooled, and after the flocculation liquid is clarified, the filtration is carried out, thus obtaining Chinese medicine extraction purification liquid 1; test 2 groups: taking the Chinese medicinal extract fluid paste, adding ethanol to ensure that the alcohol content reaches 70 percent, and filtering to obtain Chinese medicinal extraction purified liquid 2; run 3 groups: taking the Chinese medicinal extract clear paste, performing centrifugal separation at 3000r/min for 10min, refrigerating, standing for 12h, filtering, and filtering to obtain Chinese medicinal extract purified liquid 3; and detecting and analyzing the 3 parts of Chinese medicine extraction and purification solution, and determining the extract yield, the total flavone content and the total polysaccharide content in the Chinese medicine extracting solution 1, the Chinese medicine extracting solution 2 and the Chinese medicine extracting solution 3 which are processed by the purification step, and comparing the front difference and the rear difference.
Table 2 influence of different purification methods on flocculation effect of Chinese medicine extract of the present invention
From the experimental results in table 2, it can be seen that the retention rate of the effective components of the total flavonoids and the total polysaccharides in the Chinese medicine extract is the highest by adopting chitosan flocculation, although the extract yield is reduced after purification. The total polysaccharide and the total flavone in the traditional Chinese medicine extracting solution are greatly lost by adopting 70% ethanol and centrifugal separation method for treatment, and the chitosan is comprehensively compared, and the chitosan is used for treatment by adopting a chitosan purification method. In addition, the invention also carries out the inspection of the components of the pituitous substances and the tannins of the purified traditional Chinese medicine solution of the chitosan flocculating solution, and the result shows that the impurity components such as the pituitous substances, the tannins and the like in the traditional Chinese medicine extracting solution of the invention are removed by the treatment of the chitosan flocculating solution.
In conclusion, through chitosan treatment, the effective components in the traditional Chinese medicine extracting solution are relatively high in retention, so that the effective components are relatively enriched, and the granule has relatively good curative effect and good quality stability.
The preparation process of the granules
Through the screening of the preliminary experiment of the invention, the experiments are carried out on the pharmaceutic adjuvants such as starch, lactose, aerosil, microcrystalline cellulose, mannitol, hydroxypropyl methylcellulose and the like, and the pharmaceutic adjuvants with good granule formability are selected according to the following proportion: dried paste powder: the pharmaceutical excipients (or diluents) are 1:3, wherein the components of the diluents and the excipients are mannitol and lactose 3: 2. Finally weighing the traditional Chinese medicine dry paste fine powder prepared according to the invention: the proportion of the diluent is 1:3, after being mixed evenly, a small amount of ethanol is dripped, soft materials are prepared, the soft materials are screened by a 14-mesh screen, 75 percent ethanol is added, granules are prepared, the granules are dried for 30min at 65 ℃, and the granules are prepared.
Inventive sample 1 was the granules prepared by the preparation method of inventive example 1 group, and inventive sample 2 was the granules prepared by the preparation method of inventive example 2 group. The quality of the granules was evaluated separately.
TABLE 3 results of sample testing of the granules of the invention
As can be seen from the test results shown in Table 3, the quality inspection results show that the particle properties, particle size and melting performance of the granules all meet the relevant regulations of granule detection. From the above results, it can be seen that the granules prepared in example 2 of the present invention have higher contents of active ingredients of total flavonoids and total polysaccharides than the granules prepared in example 1 of the present invention, which indicates that the novel process for preparing the traditional Chinese medicine of the present invention has certain innovativeness.
Long-term stability test on the preferred traditional Chinese medicine granules (prepared by the method of the embodiment 1) and the preferred traditional Chinese medicine granules (prepared by the method of the embodiment 2) of the invention, the traditional Chinese medicine granules do not absorb moisture and have no obvious change in appearance and content after observation for 0 month, 3 months, 6 months and 12 months, which shows that the traditional Chinese medicine granules of the invention have good stability.
The Chinese medicinal materials selected by the traditional Chinese medicine have the following sources, properties, flavors, channels and efficacies, and are clinically applied as follows:
radix Linderae is rattan stem of Polygonum multiflorum Thunb of Polygonaceae. The nature and flavor of the herb enter meridians, the nature is mild, and the taste is sweet. It enters heart and liver meridians. Has effects of nourishing blood, tranquilizing mind, dispelling pathogenic wind, and dredging collaterals. It is used clinically to treat abdominal distention and pain due to adverse qi, indigestion, regurgitation, cold hernia, tinea pedis, frequent micturition, etc.
Caulis Spatholobi, rattan of Spatholobus suberectus Dunn of Leguminosae. It is warm in nature, bitter and sweet in taste. It enters liver and kidney meridians. Has effects of tonifying blood, promoting blood circulation, and dredging collaterals. It is used clinically to treat menoxenia, blood deficiency, chlorosis, numbness, paralysis, and arthralgia due to wind-dampness.
Ginseng, source, root of Panax ginseng c.a.mey. It is warm in nature, sweet and slightly bitter. They enter heart, lung, spleen and kidney meridians. Has effects of invigorating primordial qi, restoring pulse, relieving depletion, invigorating spleen, benefiting lung, promoting fluid production, and tranquilizing mind. In clinical application, the medicine is used for treating symptoms of weak body, desire for losing, shortness of breath, dyspnea, spontaneous perspiration, cold limbs, mental fatigue, poor appetite, vomiting and diarrhea, asthma due to qi deficiency or chronic cough, body fluid deficiency, thirst, diabetes, insomnia, dreaminess, palpitation with fear, amnesia, impotence, frequent micturition and all qi, blood and body fluid deficiency.
Ramulus Cinnamomi, a twig of Cinnamomum cassia Presl. It is pungent, sweet and warm in nature. It enters bladder meridian, heart meridian and lung meridian. Has the effects of relieving exterior syndrome, expelling pathogenic factors from muscles, warming meridians, activating collaterals, supporting yang, regulating qi, and calming the adverse-rising energy. The clinical application of the medicine is mainly used for treating abdominal psychroalgia, vomiting and diarrhea, soreness and coldness of waist and knees, cold hernia and abdominal pain, cold-damp arthralgia, stasis and dysmenorrheal, bloody flux, intestinal wind, traumatic swelling and pain and the like.
White peony root, source, root of Paeonia lactiflora pall. The nature and flavor enter meridians, the nature is slightly cold, the taste is bitter and sour. It enters liver and spleen meridians. Has the functions of calming liver, relieving pain, nourishing blood, regulating menstruation, astringing yin and arresting sweating. It is indicated for headache, vertigo, chest and hypochondrium pain, dysentery, abdominal pain, spontaneous perspiration, night sweat, fever due to yin deficiency, irregular menstruation, metrorrhagia, leukorrhagia, etc. in clinical practice.
Cyperus rotundus L. is a rhizome of Cyperus rotundus L. belonging to Cyperus. The nature and flavor of the herb is meridian tropism, mild nature, pungent, slightly bitter and slightly sweet. It enters liver meridian and triple energizer meridian. Has the functions of promoting the circulation of qi, resolving stagnation, regulating menstruation and relieving pain. It is used clinically to treat incoordination between liver and stomach, qi stagnation, distending pain in chest, abdomen and hypochondrium, phlegm and fluid retention, menoxenia, metrorrhagia, metrostaxis and leukorrhagia.
Angelica sinensis, source, root of Angelica sinensis (Oliv.) Diels. The nature and flavor of the herb enter meridians, the nature is warm, the taste is sweet and pungent. It enters liver meridian, heart meridian and spleen meridian. Has the effects of tonifying blood, promoting blood circulation, regulating menstruation, relieving pain, and loosening bowel to relieve constipation. It is used clinically to treat blood deficiency, sallow complexion, vertigo, palpitation, menoxenia, amenorrhea, dysmenorrhea, abdominal pain due to deficiency cold, constipation due to intestinal dryness, rheumatic arthralgia, traumatic injury, carbuncle, cellulitis, and pyocutaneous disease.
Rhubarb, the source, dried root and rhizome of Rheum palmatum L.L., Rheum tanguticum Maxim. ex Balf. or Rheum officinale Rheum j-flcinale Baill. of Polygonaceae. It is cool in nature and bitter in taste. It enters spleen meridian, stomach meridian, large intestine meridian, liver meridian and pericardium meridian. Has the effects of clearing away heat, relieving constipation, cooling blood, removing toxic substances, removing blood stasis, and dredging channels. It is used clinically to treat constipation due to excess heat, abdominal pain due to stagnation, dysentery, jaundice due to damp-heat, hematemesis and epistaxis, conjunctival congestion, pharyngeal swelling, intestinal abscess, furuncle, amenorrhea due to blood stasis, and traumatic injury.
Lumbricus, the eviscerated totality of several species of earthworms of the lumbriculidae family, the lumbriculidae Pheretima aspergillum (e.perrier), the lumbriculidae Pheretim vulgare, the lumbriculidae Pheretima guillelmi (Michaelsen), or the aspergillus pectinifera. It is cool in nature and salty in taste. It enters liver meridian, spleen meridian and bladder meridian. Has the effects of clearing away heat, arresting convulsion, dredging meridians, relieving asthma, and promoting urination. It is used clinically to treat high fever, coma, epilepsy, convulsion, arthralgia, numbness of limbs, hemiplegia, cough due to lung heat, oliguria, edema and hypertension.
Poria, sclerotium of wolf of the family Polyporaceae, Poria cocos cos (Schw.) wolf. The nature and flavor of the herb enter meridians, the nature is mild, and the taste is sweet and bland. They enter heart, lung, spleen and kidney meridians. Has the effects of promoting diuresis, eliminating dampness, invigorating spleen, and calming heart. In clinical application, it is indicated for edema, oliguria, phlegm-fluid retention, dizziness, palpitation, spleen deficiency, poor appetite, loose stool, diarrhea, uneasiness, palpitation, and insomnia.
Thunberg fritillary bulb, source, bulb of Fritillaria thunbergii Mig. It is cool in nature and bitter in taste. It enters lung meridian and heart meridian. Has the effects of clearing away heat, dispersing pathogenic accumulation, eliminating phlegm, and relieving cough. It is indicated for cough due to wind-heat, lung abscess, sore throat, scrofula, sores and ulcers, and other diseases in clinical practice.
Notoginseng radix, root and rhizome of Panax notoginseng (Burk.) F.H.Chen. It is warm in nature, sweet and slightly bitter. It enters liver meridian and stomach meridian. Has the functions of eliminating blood stasis, stopping bleeding, eliminating swelling and relieving pain. It is used clinically to treat hemoptysis, hematemesis, epistaxis, hematochezia, metrorrhagia, traumatic hemorrhage, thoracico-abdominal pain, and traumatic swelling and pain.
Spina Gleditsiae, spina Gleditsiae of Gleditsia sinensis Lam. The nature and flavor enter meridians, the nature is warm, and the taste is pungent. It enters liver meridian and stomach meridian. Has the functions of relieving swelling, expelling toxin, expelling pus and killing parasites. It is indicated for early stage of abscess or pus formation without ulceration in clinic.
Trichosanthis radix, root of Trichosanthes rosthornii Harms. or Trichosanthes kirilowii Maxim. belonging to Cucurbitaceae family. It is slightly cold in nature, sweet and slightly bitter in taste. It enters lung and stomach meridians. Has the effects of clearing away heat, promoting salivation, relieving swelling, and expelling pus. It is used clinically to treat fever with polydipsia, lung heat with dry cough, internal heat with thirst, pyocutaneous disease with toxic swelling.
The traditional Chinese medicine has the beneficial effects that:
the Chinese medicine is prepared by obtaining a clinically effective prescription for treating the hyperplasia of mammary glands under the guidance of the traditional Chinese medicine theory and clinical experience. The prescription mainly comprises fourteen medicinal materials of radix linderae, caulis spatholobi, ginseng, cassia twig, white paeony root and the like. The traditional Chinese medicine composition has the effects of tonifying qi and nourishing blood, soothing liver and warming yang, dissolving stasis and relieving pain, and softening hardness and dissipating stagnation, is clinically used for treating symptoms of lump and pain in breast, small menstrual amount, intolerance of cold, chest and hypochondrium distending pain, mental fatigue and hypodynamia and the like, and is particularly suitable for nodules of breast patients with Chong and conception vessel disorder, liver depression and qi stagnation and yang deficiency symptoms.
The compatibility of the prescription is characterized in that: the whole formula mainly replenishes qi and warms yang, and is assisted by nourishing blood and dredging collaterals, so that the liver qi of women is relaxed, the yang qi is sufficient to remove cold evil, the qi and blood run smoothly, the venation is self-communicated, and the breast nodules of the women are eliminated. The combination of the qi-regulating herbs and the combined spicebush root and white peony root can nourish blood and nourish yin, and the combination of the Chinese honeylocust spine can lead the herbs to move upwards, so that the diseases of the herbs such as breast, qi and blood, liver qi and breast nodules can be gradually and automatically eliminated.
The chitosan flocculation method is adopted in the traditional Chinese medicine preparation process, so that the retention and enrichment degree of active ingredients such as total flavonoids and total polysaccharides in the traditional Chinese medicine extracting solution is improved, impurities such as tannin and mucilage in the extracting solution can be well removed, the stability of the granules is improved, the traditional Chinese medicine preparation process is more scientific and reasonable, and the requirement of industrial large-scale production is met.
According to the clinical test results of the traditional Chinese medicines, the total clinical effective rate of the test 1 group is 71.4%, while the total clinical effective rate of the test 2 group is 88.9%, and no adverse reaction is found in the patients in the using process.
In conclusion, the preparation process technology of the traditional Chinese medicine is stable and reliable, and has good market application prospect.
Drawings
The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description serve to explain the invention and not to limit the invention.
FIG. 1 is a flow chart of a production process of the traditional Chinese medicine granule of the invention;
figure 2-graph of appearance samples of the traditional Chinese medicine granules of the invention.
Detailed Description
The following are specific examples of the present invention and further describe the technical solutions of the present invention, but the scope of the present invention is not limited to these examples. All changes, modifications and equivalents that do not depart from the spirit of the invention are intended to be included within the scope thereof.
Example 1
Taking 100g of radix linderae, 100g of caulis spatholobi, 80g of ginseng, 80g of cassia twig, 80g of radix paeoniae alba, 60g of rhizoma cyperi, 60g of angelica, 60g of rheum officinale, 60g of earthworm, 60g of poria cocos, 60g of thunberg fritillary bulb, 60g of pseudo-ginseng, 50g of spina gleditsiae and 50g of radix trichosanthis, adding water 9 times the weight of the medicinal materials for the first time, decocting for 1 hour, filtering, adding water 7 times the weight of the medicinal materials for the second time, decocting for 0.6 hour, filtering, combining water-decocted filtrates of two times, concentrating the filtrate under reduced pressure into a clear paste with the relative density of 1.02-1.06, concentrating and drying under reduced pressure, concentrating and drying under the temperature of 60 ℃ and the vacuum degree of 0.06-0.10 MPa, drying for 40 minutes to obtain dry paste powder, crushing and;
the preparation method comprises the steps of mixing fine dried paste powder uniformly, adding a diluent (mannitol: lactose 3:2), and mixing the fine dried paste powder: the diluent is mixed uniformly in a ratio of 1:3, and then 75% ethanol is added to prepare granules, and the granules are dried for 30min at 65 ℃ and are sized to obtain the traditional Chinese medicine granules.
Example 2
Taking 100g of radix linderae, 100g of caulis spatholobi, 80g of ginseng, 80g of cassia twig, 80g of radix paeoniae alba, 60g of rhizoma cyperi, 60g of angelica sinensis, 60g of rheum officinale, 60g of earthworm, 60g of poria cocos, 60g of thunberg fritillary bulb, 60g of pseudo-ginseng, 50g of spina gleditsiae and 50g of radix trichosanthis, adding water 9 times the weight of the medicinal materials for the first time, decocting for 1h, filtering, adding water 7 times the weight of the medicinal materials for the second time, decocting for 0.6h, filtering, combining water filtrates of the two times, concentrating the filtrate under reduced pressure into clear paste with relative density of 1.02-1.06, adding chitosan solution for purification, adding the chitosan solution with concentration of 3%, adding the chitosan solution with volume of 10% of the Chinese medicine purified solution, controlling the temperature at 50 ℃, stirring for 10 minutes to obtain Chinese medicine purified solution, concentrating and drying under reduced pressure, concentrating and drying at the temperature of 60 ℃ and the vacuum degree of 0., drying for 40 min to obtain dry extract powder, pulverizing and sieving to obtain mixed dry extract fine powder;
the preparation method comprises the steps of mixing fine dried paste powder uniformly, adding a diluent (mannitol: lactose 3:2), and mixing the fine dried paste powder: the diluent is mixed uniformly in a ratio of 1:3, and then 75% ethanol is added to prepare granules, and the granules are dried for 30min at 65 ℃ and are sized to obtain the traditional Chinese medicine granules.
Example 3
Firstly, adding water in an amount which is 10 times of the weight of medicinal materials for 2 hours, decocting, filtering, adding water in an amount which is 9 times of the weight of the medicinal materials for the second time, decocting for 0.5 hour, filtering, combining water filtrates of two times, concentrating the filtrate under reduced pressure to obtain a clear paste with a relative density of 1.02-1.06, concentrating and drying under reduced pressure at a temperature of 60 ℃, and a vacuum degree of 0.08-0.12 MPa for 50 minutes to obtain dry paste powder, crushing and sieving to obtain mixed fine paste;
the preparation method comprises the steps of mixing fine dried paste powder uniformly, adding a diluent (lactose: dextrin 2:2), and mixing the fine dried paste powder: the diluent is mixed uniformly in a ratio of 1:3, and then 75% ethanol is added to prepare granules, and the granules are dried for 25min at 60 ℃ and are sized to obtain the traditional Chinese medicine granules.
Example 4
Taking 90g of radix linderae, 90g of caulis spatholobi, 70g of ginseng, 90g of cassia twig, 50g of radix paeoniae alba, 70g of rhizoma cyperi, 50g of angelica, 70g of rheum officinale, 50g of earthworm, 50g of poria cocos, 70g of thunberg fritillary bulb, 50g of pseudo-ginseng, 40g of spina gleditsiae and 40g of radix trichosanthis, adding water in an amount which is 7 times of the weight of the medicinal materials for the first time, decocting for 0.5h, filtering, adding water in an amount which is 6 times of the weight of the medicinal materials for the second time, decocting for 1h, filtering, combining water filtrates of the two times, concentrating the filtrate under reduced pressure into a clear paste with a relative density of 1.02-1.06, concentrating and drying under reduced pressure, concentrating and drying under a temperature of 65 ℃ and a vacuum degree of 0.08-0.11 MPa;
the preparation method comprises the steps of mixing fine dried paste powder uniformly, adding a diluent (starch: dextrin 2:2), and mixing the fine dried paste powder: the diluent is mixed uniformly in a ratio of 1:3, and then 75% ethanol is added to prepare granules, and the granules are dried for 25min at 60 ℃ and are sized to obtain the traditional Chinese medicine granules.
Example 5
Taking 100g of radix linderae, 110g of caulis spatholobi, 80g of ginseng, 90g of cassia twig, 50g of radix paeoniae alba, 70g of rhizoma cyperi, 50g of angelica, 70g of rheum officinale, 60g of earthworm, 60g of poria cocos, 70g of thunberg fritillary bulb, 50g of pseudo-ginseng, 60g of spina gleditsiae and 60g of radix trichosanthis, adding water with the weight ratio of 8 times of that of the medicinal materials for the first time, decocting for 1h, filtering, adding water with the weight ratio of 8 times of that of the medicinal materials for the second time, decocting for 1h, filtering, combining water filtrate obtained in two times, concentrating the filtrate under reduced pressure into clear paste with the relative density of 1.02-1.06, concentrating and drying under reduced pressure, concentrating and drying at the temperature of 70 ℃, concentrating and drying under the vacuum degree of 0.06-0.12 MPa for 30;
the preparation method comprises the steps of mixing fine dried paste powder uniformly, adding a diluent (mannitol and microcrystalline cellulose in a ratio of 3:2), and mixing the fine dried paste powder: the diluent is mixed uniformly in a ratio of 1:3, and then 75% ethanol is added to prepare granules, and the granules are dried for 30min at 60 ℃ and are sized to obtain the traditional Chinese medicine granules.
Example 6
Taking 110g of radix linderae, 100g of caulis spatholobi, 80g of ginseng, 80g of cassia twig, 70g of radix paeoniae alba, 50g of rhizoma cyperi, 60g of angelica, 60g of rheum officinale, 70g of earthworm, 50g of poria cocos, 60g of thunberg fritillary bulb, 60g of pseudo-ginseng, 50g of spina gleditsiae and 50g of radix trichosanthis, adding water 9 times the weight of the medicinal materials for the first time, decocting for 1h, filtering, adding water 9 times the weight of the medicinal materials for the second time, decocting for 1h, filtering, combining water filtrates of two times, concentrating the filtrate under reduced pressure into a clear paste with the relative density of 1.02-1.06, concentrating and drying under reduced pressure to obtain dry paste powder, crushing and sieving to obtain mixed dry paste fine;
the preparation method comprises the steps of mixing fine dried paste powder uniformly, adding a diluent (starch and microcrystalline cellulose in a ratio of 3:2), and mixing the fine dried paste powder: the proportion of the diluent is 1:3, after being mixed evenly, the mixture is added with 75 percent ethanol for preparing particles, and the particles are dried for 35min at 60 ℃ and are sized, thus obtaining the granules.
Example 6
Taking 90g of radix linderae, 100g of caulis spatholobi, 70g of ginseng, 80g of cassia twig, 50g of radix paeoniae alba, 70g of rhizoma cyperi, 50g of angelica, 70g of rheum officinale, 60g of earthworm, 60g of poria cocos, 60g of thunberg fritillary bulb, 50g of pseudo-ginseng, 60g of spina gleditsiae and 60g of radix trichosanthis, adding water 9 times the weight of the medicinal materials for the first time, decocting for 1h, filtering, adding water 7 times the weight of the medicinal materials for the second time, decocting for 0.8h, filtering, combining water filtrates of the two times, concentrating the filtrate under reduced pressure into clear paste with relative density of 1.02-1.06, adding chitosan solution for purification, adding the chitosan solution with concentration of 2.5%, adding the chitosan solution with volume of 15% of the volume of the Chinese medicine purified solution, controlling the temperature at 55 ℃, stirring for 8 minutes, obtaining the Chinese medicine purified solution, concentrating and drying under reduced pressure, concentrating and drying at the temperature of 65 ℃ and the vacuum degree, drying for 40 min to obtain dry extract powder, pulverizing and sieving to obtain mixed dry extract fine powder;
the preparation method comprises the steps of mixing fine dried paste powder uniformly, adding a diluent (mannitol and microcrystalline cellulose 2:2), and mixing the fine dried paste powder: the diluent is mixed uniformly in a ratio of 1:3, and then 70% ethanol is added to prepare granules, and the granules are dried for 30min at 65 ℃ and are sized, so that the traditional Chinese medicine granules are obtained.
Example 7
Taking 100g of radix linderae, 90g of caulis spatholobi, 90g of ginseng, 80g of cassia twig, 60g of radix paeoniae alba, 50g of rhizoma cyperi, 60g of angelica sinensis, 60g of rheum officinale, 50g of earthworm, 60g of poria cocos, 50g of thunberg fritillary bulb, 60g of pseudo-ginseng, 50g of spina gleditsiae and 40g of radix trichosanthis, adding water with the weight ratio of 8 times of that of the medicinal materials for the first time, decocting for 2 hours, filtering, adding water with the weight ratio of 7 times of that of the medicinal materials for the second time, decocting for 0.5 hour, filtering, combining water filtrates of the two times, concentrating the filtrate under reduced pressure into clear paste with the relative density of 1.02-1.06, adding a chitosan solution for purification, adding the chitosan solution with the concentration of 3.5%, adding the chitosan solution with the volume of 8% of the Chinese medicine purified solution, controlling the temperature at 55 ℃, stirring for 6 minutes, obtaining a Chinese medicine purified solution, concentrating and;
the preparation method comprises the steps of mixing fine dried paste powder uniformly, adding a diluent (starch and microcrystalline cellulose in a ratio of 3:2), and mixing the fine dried paste powder: the proportion of the diluent is 1:3, after being mixed evenly, the mixture is added with 75 percent ethanol for preparing particles, and the particles are dried for 35min at 60 ℃ and are sized, thus obtaining the granules.
In order to further verify the clinical efficacy of the traditional Chinese medicine of the present invention, the finished granules prepared in the above-mentioned groups of specific examples 1 and 2 were subjected to corresponding clinical tests, and the test results are summarized as follows.
1 clinical observations of the Chinese medicine of the invention
1.1 general data
The invention relates to a research experiment, which treats 103 cases of patients with hyperplasia of mammary glands, after the consent of the patients is obtained, all cases conform to the diagnosis standard of patients with hyperplasia of mammary glands in the 'traditional Chinese medicine syndrome diagnosis curative effect standard' issued by the national traditional Chinese medicine administration of 1994, and for women, pregnant women suffering from hypertension, diabetes, neoplastic disease, liver and kidney function damage, mental diseases, pregnancy or lactation are excluded, and the selected patients are 2 months before treatment, and other medicines are stopped taking.
All patients were randomized into two groups, 49 in treatment 1 and 54 in treatment 2. Wherein, the patients in the experiment 1 group are 28-56 years old, the average age is 39.5 +/-2.1 years old, the course is 4 months-3.6 years old, and the average course is 2.3 +/-0.9 years old; according to the experiment 2, the patients are 26-63 years old, the average age (37.1 +/-1.8) years old, the disease course is 5 months-4.2 years old, and the average disease course (2.1 +/-0.8) years old, and after arrangement statistical analysis, the difference of the ages, the disease courses and the disease conditions of the two groups of patients is not statistically significant (P is more than 0.05), and the patients have comparability.
1.2 therapeutic criteria
The clinical test of the invention refers to the diagnosis standard of the patients with hyperplasia of mammary glands in the 'standard of curative effect for diagnosing the traditional Chinese medicine diseases' issued by the State administration of traditional Chinese medicine. The treatment effect is comprehensively evaluated: firstly, effect is shown: after the patient is treated, the lump and pain of the breast and the mammary gland disappear. Secondly, effectively: after the patient is treated, the breast lump is reduced, and the breast pain is relieved or disappeared. ③, invalid: after the treatment, the size of the breast lump is unchanged, the symptoms of breast pain are not relieved, and the size of the breast lump is unchanged. Total effective rate (%) + effective rate (%).
1.3 methods of treatment
Inventive test 1 group: the granules prepared according to the preparation method of example 1 of the present invention were orally administered at 6 g/time and 3 times/day, and were taken during the menstrual period of patients. 1 month is a course of treatment, the medicine is stopped during menstrual period, and after continuously taking the medicine for 3 courses, the clinical curative effect of the patient is evaluated.
Inventive test 2 groups: the granules prepared according to the preparation method of example 2 of the present invention were orally administered at 6 g/time and 3 times/day, and were taken out during the menstrual period of the patients. 1 month is a course of treatment, the patients can stop taking the medicine during the menstrual period, and the clinical efficacy of the patients is evaluated after continuously taking the medicine for 3 courses.
1.4 therapeutic results
TABLE 4 comparison of clinical efficacy of two groups of patients
As can be seen from the results in Table 4, after 3 months of drug treatment, the breast mass of the patients treated in the trial treatment group 1 of the present invention is reduced, the pain of the patients is obviously relieved, and the total clinical effective rate is 71.4%. For the patients of the trial 2 groups who took the granules prepared in the group of example 2 of the present invention, the clinical effective rate was 88.9%. The results show that the clinical efficacy of the patients in trial 2 of the invention is significantly better than that in trial 1 of the invention. The traditional Chinese medicine has a satisfactory effect on treating hyperplasia of mammary glands, has small toxic and side effects, and is safe and effective. No adverse reactions were observed during the treatment of the 2 patients.
In conclusion, the traditional Chinese medicine granules have definite clinical curative effect, reliable and stable preparation process and lower production cost in the aspect of treating the hyperplasia of mammary glands, and have good market application and popularization prospects.
Claims (6)
1. The traditional Chinese medicine for treating nodules of breasts is characterized by being prepared from the following raw material medicines in parts by weight: 90-110 parts of radix linderae, 90-110 parts of caulis spatholobi, 70-90 parts of ginseng, 70-90 parts of cassia twig, 50-70 parts of white paeony root, 50-70 parts of rhizoma cyperi, 50-70 parts of angelica sinensis, 50-70 parts of rheum officinale, 50-70 parts of earthworm, 50-70 parts of poria cocos, 50-70 parts of thunberg fritillary bulb, 50-70 parts of pseudo-ginseng, 40-60 parts of spina gleditsiae and 40-60 parts of trichosanthes root.
2. The traditional Chinese medicine according to claim 1, which is prepared from the following raw material medicines in parts by weight: 95-105 parts of radix linderae, 95-105 parts of caulis spatholobi, 75-85 parts of ginseng, 75-85 parts of cassia twig, 55-65 parts of radix paeoniae alba, 55-65 parts of rhizoma cyperi, 55-65 parts of angelica sinensis, 55-65 parts of rheum officinale, 55-65 parts of lumbricus, 55-65 parts of poria cocos, 55-65 parts of thunberg fritillary bulb, 55-65 parts of pseudo-ginseng, 45-55 parts of spina gleditsiae and 45-55 parts of trichosanthes root.
3. The traditional Chinese medicine according to claim 1, which is prepared from the following raw material medicines in parts by weight: 100 parts of radix linderae, 100 parts of caulis spatholobi, 80 parts of ginseng, 80 parts of cassia twig, 60 parts of radix paeoniae alba, 60 parts of rhizoma cyperi, 60 parts of angelica, 60 parts of rheum officinale, 60 parts of earthworm, 60 parts of poria cocos, 60 parts of thunberg fritillary bulb, 60 parts of pseudo-ginseng, 50 parts of spina gleditsiae and 50 parts of trichosanthes root.
4. The method for preparing the traditional Chinese medicine according to claim 1, wherein the preparation method comprises the following steps:
taking radix linderae, caulis spatholobi, ginseng, cassia twig, radix paeoniae alba, rhizoma cyperi, angelica sinensis, rheum officinale, earthworm, poria cocos, thunberg fritillary bulb, pseudo-ginseng, spina gleditsiae and radix trichosanthis, adding water 7-10 times of the weight of the medicinal materials for the first time, decocting for 0.5-2 hours, filtering, adding water 6-9 times of the weight of the medicinal materials for the second time, decocting for 0.5-1 hour, filtering, combining water filtrates of the two times, concentrating the filtrate under reduced pressure into a clear paste with the relative density of 1.02-1.06, concentrating and drying under reduced pressure to obtain dry paste powder, crushing and sieving to obtain mixed dry paste fine powder;
the method comprises the steps of mixing fine dry paste powder, uniformly mixing, and adding common auxiliary materials in pharmacy.
5. The method for preparing the traditional Chinese medicine according to claim 4, wherein the preparation method comprises the following steps:
the preparation method comprises the steps of taking radix linderae, caulis spatholobi, ginseng, cassia twig, radix paeoniae alba, rhizoma cyperi, angelica sinensis, rheum officinale, earthworm, poria cocos, thunberg fritillary bulb, pseudo-ginseng, spina gleditsiae and radix trichosanthis, adding water 9 times the weight of the medicinal materials for the first time, decocting for 1 hour, filtering, adding water 8 times the weight of the medicinal materials for the second time, decocting for 0.6 hour, filtering, combining water filtrate obtained in the two times, concentrating the filtrate under reduced pressure into a clear paste with the relative density of 1.02-1.06, concentrating and drying under reduced pressure to obtain dry paste powder, crushing and sieving to obtain mixed dry paste fine powder;
the method comprises the steps of mixing fine dry paste powder, uniformly mixing, and adding common auxiliary materials in pharmacy.
6. The traditional Chinese medicine of claim 1, wherein the dosage form of the traditional Chinese medicine is preferably granules.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110147212.2A CN112791147A (en) | 2021-02-03 | 2021-02-03 | Traditional Chinese medicine for treating nodules of breast and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110147212.2A CN112791147A (en) | 2021-02-03 | 2021-02-03 | Traditional Chinese medicine for treating nodules of breast and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112791147A true CN112791147A (en) | 2021-05-14 |
Family
ID=75813871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110147212.2A Pending CN112791147A (en) | 2021-02-03 | 2021-02-03 | Traditional Chinese medicine for treating nodules of breast and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112791147A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1183974A (en) * | 1996-12-04 | 1998-06-10 | 张淑贤 | A traditional herb medicine pill for treating mammary gland lobes proliferation |
CN1965990A (en) * | 2006-04-03 | 2007-05-23 | 米黎 | Medicament for preventing and treating benign hyperplasia of mammary glands in women and preparation process thereof |
CN105381414A (en) * | 2015-12-23 | 2016-03-09 | 青岛友诚高新技术有限公司 | Traditional Chinese medicine preparation for treating breast lumps and cystic hyperplasia and preparation method thereof |
-
2021
- 2021-02-03 CN CN202110147212.2A patent/CN112791147A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1183974A (en) * | 1996-12-04 | 1998-06-10 | 张淑贤 | A traditional herb medicine pill for treating mammary gland lobes proliferation |
CN1965990A (en) * | 2006-04-03 | 2007-05-23 | 米黎 | Medicament for preventing and treating benign hyperplasia of mammary glands in women and preparation process thereof |
CN105381414A (en) * | 2015-12-23 | 2016-03-09 | 青岛友诚高新技术有限公司 | Traditional Chinese medicine preparation for treating breast lumps and cystic hyperplasia and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103990081B (en) | Traditional Chinese medicine composition and application thereof in preparation of medicine for treating infant jaundice | |
CN103933220B (en) | Medicine for treating climacteric syndrome | |
CN113018405A (en) | Traditional Chinese medicine composition for treating post-stroke depression and preparation method thereof | |
CN110013470B (en) | Application of Shenbao tablet in preparing medicine for treating sequelae of pelvic inflammatory disease | |
CN113713039A (en) | Traditional Chinese medicine composition for treating membranous nephropathy and application thereof | |
CN109528980A (en) | A kind of Chinese medicine composition and its pharmacy application for treating Ovary reserve decline disease | |
CN108721431B (en) | Traditional Chinese medicine composition for removing heavy metals and application thereof | |
CN110613777A (en) | Traditional Chinese medicine composition for treating phlegm-damp stagnation type polycystic ovarian syndrome | |
CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
CN105944020B (en) | Traditional Chinese medicine for treating ovarian function decline | |
CN112791147A (en) | Traditional Chinese medicine for treating nodules of breast and preparation method thereof | |
CN112704723A (en) | A Chinese medicinal preparation for treating dysmenorrhea and its preparation method | |
CN105902951A (en) | Traditional Chinese medicinal compound for treating osteosarcomas on basis of chemotherapeutic drugs | |
CN112791146B (en) | Traditional Chinese medicine composition for treating chronic renal failure | |
CN110960646A (en) | Preparation method of Yunkang oral liquid | |
CN109331097B (en) | Stagnation-resolving liver-softening granule and preparation process thereof | |
CN104162090B (en) | Pharmaceutical composition and preparation method thereof | |
CN111658748A (en) | Composition for treating dysmenorrhea, oral preparation and application | |
CN109718283B (en) | Traditional Chinese medicine composition for relieving asthma and reducing phlegm and preparation method thereof | |
CN103263558A (en) | Traditional Chinese medicine composition for treating breast hyperplasia and preparation method thereof | |
CN111195299B (en) | Chinese medicinal composition for treating hepatic fibrosis and preparation method thereof | |
CN114796417B (en) | Blood sugar reducing traditional Chinese medicine formula and preparation method thereof | |
CN102198251A (en) | Chinese medicinal composition for treating climacteric syndrome and preparation method thereof | |
CN109718280B (en) | A Chinese medicinal composition for treating female climacteric syndrome, and its preparation method | |
Li et al. | Traditional Chinese medicine prescriptions and herbs for the treatment of hypothyroidism: a narrative review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210514 |
|
RJ01 | Rejection of invention patent application after publication |